Business Context and Reporting Period
This Form 6-K filing by Sanofi-Aventis (formerly Sanofi-Synthelabo) covers the period ending December 15, 2004. The report details the conclusion of a mandatory tender offer for shares in Hoechst Aktiengesellschaft.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the results of a corporate acquisition tender offer.
Material Changes
As of the close of the tender period on December 15, 2004, at 18:00 CET:
- Shares Tendered: 583,515 shares of Hoechst Aktiengesellschaft were accepted.
- Percentage Acquired in Offer: The tendered shares represent 0.10% of Hoechst's share capital and voting rights.
- Total Ownership: Following this offer, Sanofi-Aventis and its affiliates (including subsidiary Aventis) own 98.19% of the share capital and voting rights of Hoechst Aktiengesellschaft.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The primary disclosure is the successful consolidation of ownership in Hoechst Aktiengesellschaft.
Investor Verification Points
- Verify the final ownership percentage of 98.19% in Hoechst Aktiengesellschaft.
- Confirm the number of shares tendered (583,515) and the date of the tender close (December 15, 2004).
- Note that this filing does not contain quarterly or annual financial results; investors should refer to Form 20-F for financial data.